IMEXHS LIMITED — Capital/Financing Update 2020

Aug 16, 2020

17 August 2020

==> picture [116 x 30] intentionally omitted <==

ASX ANNOUNCEMENT

Debt Repayment and placement of shares

IMEXHS Limited (ASX: IME) (“IMEXHS” or “the Company”) is pleased to announce its intention to repay $1 million of borrowings from Domatorisaro Pty Ltd (a company associated with IMEXHS Director, Dr Doug Lingard) during August 2020. In addition, the Company announces today the proposed placement to Domatorisaro Pty Ltd (or its nominees) of 16,666,667 fully paid ordinary shares at an issue price of $0.03 per share, for a total of $500,000 in cash. The proposed placement is subject to shareholder approval, expected to be sought at a general meeting of shareholders to be held late October/November 2020.

IMEXHS Chairman, Doug Flynn said “This is a strong statement of support from Dr Lingard and has the effect of improving the balance sheet of the Company, with a reduction in borrowings, current liabilities and interest cost and an increase in equity. It reflects conviction in the Company’s strategy and in its execution.”

IMEXHS currently expects to release its half-year results on 31 August 2020.

Authorised for release by the Board of IMEXHS Limited.

-ENDS-

For more information, please contact: Media and Investor Relations

Francoise Dixon, Citadel-MAGNUS E: fdixon@citadelmagnus.com T: +61 412 292 977

Business Inquiries

Tony Thomas – CFO IMEXHS E: enquiries@imexhs.com.au T: +61 (0)2-9030-0040

About IMEXHS

IMEXHS Limited [ASX: IME] is a leading imaging Software-as-a-Service (SaaS) and ancillary solutions provider with 227 customers and distributors in 15 countries. Founded in 2012, IMEXHS is known for its innovation in the imaging services market, offering flexible and scalable imaging solutions via its HIRUKO branded suite of solutions for next generation Picture Archiving and Communications System (PACS) and integrated medical imaging systems (including a Radiology Information System (RIS), a Cardiology Information System (CIS) and an Anatomical Pathology Laboratory Information System (APLIS)). The HIRUKO system is completely cloud-based, vendor neutral and zero footprint with no need for installed software. The IMEXHS products are designed to increase productivity and save money for end users, with a scalable platform that is configured for the future and enhances patient outcomes. For more information, visit www.imexhs.com

IMEXHS Limited ABN 60 096 687 839 Imaging Experts and Healthcare Services Pty Ltd ABN 18 624 772 756 122 O’Riordan Street, Mascot NSW 2020 Tel: +61 2 9030 0040